“Integrating Artelon’s portfolio into Stryker’s offerings will allow us to deliver best-in-class soft tissue fixation solutions,” said
Artelon’s technologies complement and expand the current range of products available to Stryker’s foot and ankle and sports medicine specialist customers. Its differentiated synthetic technology is designed to enhance biological and mechanical ligament and tendon reconstruction with over 60,000 implantations worldwide.
“The acquisition of Artelon will offer enhanced solutions in the soft tissue fixation segment, enhancing our ability to meet the diverse needs of our customers,” said
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715821564/en/
Director, Communications, Trauma & Extremities
Frank.Mastrangelo@stryker.com
Source: Stryker